List of Tables
Table 1. Global Intravenous Immunoglobulin(IVIg) Therapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Intravenous Immunoglobulin(IVIg) Therapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Intravenous Immunoglobulin(IVIg) Therapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Intravenous Immunoglobulin(IVIg) Therapy Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Intravenous Immunoglobulin(IVIg) Therapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, Product Type & Application
Table 12. Global Key Manufacturers of Intravenous Immunoglobulin(IVIg) Therapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Intravenous Immunoglobulin(IVIg) Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Intravenous Immunoglobulin(IVIg) Therapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2020-2025) & (K Units)
Table 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2020-2025)
Table 19. Global Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2026-2031) & (K Units)
Table 20. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2026-2031)
Table 21. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2020-2025)
Table 23. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2026-2031)
Table 25. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025) & (K Units)
Table 27. North America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2026-2031) & (K Units)
Table 28. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Type (2020-2025)
Table 51. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Type (2026-2031)
Table 52. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2020-2025)
Table 53. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Type (2026-2031)
Table 54. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2020-2025)
Table 57. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Type (2026-2031)
Table 58. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Type (2020-2025)
Table 59. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Type (2026-2031)
Table 60. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Application (2020-2025)
Table 61. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units) by Application (2026-2031)
Table 62. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2020-2025)
Table 63. Global Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Application (2026-2031)
Table 64. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2020-2025)
Table 67. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Application (2026-2031)
Table 68. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Application (2020-2025)
Table 69. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Application (2026-2031)
Table 70. TEIJIN LIMITED Company Information
Table 71. TEIJIN LIMITED Description and Business Overview
Table 72. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. TEIJIN LIMITED Intravenous Immunoglobulin(IVIg) Therapy Product
Table 74. TEIJIN LIMITED Recent Developments/Updates
Table 75. Grifols Company Information
Table 76. Grifols Description and Business Overview
Table 77. Grifols Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Grifols Intravenous Immunoglobulin(IVIg) Therapy Product
Table 79. Grifols Recent Developments/Updates
Table 80. Biotest Company Information
Table 81. Biotest Description and Business Overview
Table 82. Biotest Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Biotest Intravenous Immunoglobulin(IVIg) Therapy Product
Table 84. Biotest Recent Developments/Updates
Table 85. Kamada Company Information
Table 86. Kamada Description and Business Overview
Table 87. Kamada Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Kamada Intravenous Immunoglobulin(IVIg) Therapy Product
Table 89. Kamada Recent Developments/Updates
Table 90. Takeda Company Information
Table 91. Takeda Description and Business Overview
Table 92. Takeda Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Takeda Intravenous Immunoglobulin(IVIg) Therapy Product
Table 94. Takeda Recent Developments/Updates
Table 95. Octapharma Company Information
Table 96. Octapharma Description and Business Overview
Table 97. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Octapharma Intravenous Immunoglobulin(IVIg) Therapy Product
Table 99. Octapharma Recent Developments/Updates
Table 100. Kedrion Company Information
Table 101. Kedrion Description and Business Overview
Table 102. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Kedrion Intravenous Immunoglobulin(IVIg) Therapy Product
Table 104. Kedrion Recent Developments/Updates
Table 105. LFB Group Company Information
Table 106. LFB Group Description and Business Overview
Table 107. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. LFB Group Intravenous Immunoglobulin(IVIg) Therapy Product
Table 109. LFB Group Recent Developments/Updates
Table 110. Baxter Company Information
Table 111. Baxter Description and Business Overview
Table 112. Baxter Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Baxter Intravenous Immunoglobulin(IVIg) Therapy Product
Table 114. Baxter Recent Developments/Updates
Table 115. Nanyue Biopharming Company Information
Table 116. Nanyue Biopharming Description and Business Overview
Table 117. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. Nanyue Biopharming Intravenous Immunoglobulin(IVIg) Therapy Product
Table 119. Nanyue Biopharming Recent Developments/Updates
Table 120. Boya-Bio Company Information
Table 121. Boya-Bio Description and Business Overview
Table 122. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 123. Boya-Bio Intravenous Immunoglobulin(IVIg) Therapy Product
Table 124. Boya-Bio Recent Developments/Updates
Table 125. CSL Plasma Company Information
Table 126. CSL Plasma Description and Business Overview
Table 127. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 128. CSL Plasma Intravenous Immunoglobulin(IVIg) Therapy Product
Table 129. CSL Plasma Recent Developments/Updates
Table 130. CNBG Company Information
Table 131. CNBG Description and Business Overview
Table 132. CNBG Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 133. CNBG Intravenous Immunoglobulin(IVIg) Therapy Product
Table 134. CNBG Recent Developments/Updates
Table 135. Beijing Tiantan Biological Products Company Information
Table 136. Beijing Tiantan Biological Products Description and Business Overview
Table 137. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 138. Beijing Tiantan Biological Products Intravenous Immunoglobulin(IVIg) Therapy Product
Table 139. Beijing Tiantan Biological Products Recent Developments/Updates
Table 140. Hualan Bio Company Information
Table 141. Hualan Bio Description and Business Overview
Table 142. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 143. Hualan Bio Intravenous Immunoglobulin(IVIg) Therapy Product
Table 144. Hualan Bio Recent Developments/Updates
Table 145. Guangdong Shuagnlin Bio-pharmacy Company Information
Table 146. Guangdong Shuagnlin Bio-pharmacy Description and Business Overview
Table 147. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 148. Guangdong Shuagnlin Bio-pharmacy Intravenous Immunoglobulin(IVIg) Therapy Product
Table 149. Guangdong Shuagnlin Bio-pharmacy Recent Developments/Updates
Table 150. Weiguang Biological Company Information
Table 151. Weiguang Biological Description and Business Overview
Table 152. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 153. Weiguang Biological Intravenous Immunoglobulin(IVIg) Therapy Product
Table 154. Weiguang Biological Recent Developments/Updates
Table 155. Sinopharm Company Information
Table 156. Sinopharm Description and Business Overview
Table 157. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 158. Sinopharm Intravenous Immunoglobulin(IVIg) Therapy Product
Table 159. Sinopharm Recent Developments/Updates
Table 160. Shanghai RAAS Company Information
Table 161. Shanghai RAAS Description and Business Overview
Table 162. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 163. Shanghai RAAS Intravenous Immunoglobulin(IVIg) Therapy Product
Table 164. Shanghai RAAS Recent Developments/Updates
Table 165. Taibang Biologic Group Company Information
Table 166. Taibang Biologic Group Description and Business Overview
Table 167. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 168. Taibang Biologic Group Intravenous Immunoglobulin(IVIg) Therapy Product
Table 169. Taibang Biologic Group Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Intravenous Immunoglobulin(IVIg) Therapy Distributors List
Table 173. Intravenous Immunoglobulin(IVIg) Therapy Customers List
Table 174. Intravenous Immunoglobulin(IVIg) Therapy Market Trends
Table 175. Intravenous Immunoglobulin(IVIg) Therapy Market Drivers
Table 176. Intravenous Immunoglobulin(IVIg) Therapy Market Challenges
Table 177. Intravenous Immunoglobulin(IVIg) Therapy Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
Table 181. Authors List of This Report
List of Figures
Figure 1. Product Picture of Intravenous Immunoglobulin(IVIg) Therapy
Figure 2. Global Intravenous Immunoglobulin(IVIg) Therapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Type: 2024 & 2031
Figure 4. 1g/20ml Product Picture
Figure 5. 1.25g/25ml Product Picture
Figure 6. 2.5g/50ml Product Picture
Figure 7. 5g/100ml Product Picture
Figure 8. 10g/200ml Product Picture
Figure 9. Others Product Picture
Figure 10. Global Intravenous Immunoglobulin(IVIg) Therapy Market Value by Application (2020-2031) & (US$ Million)
Figure 11. Global Intravenous Immunoglobulin(IVIg) Therapy Market Share by Application: 2024 & 2031
Figure 12. Immunodeficiency
Figure 13. Autoimmune Disease
Figure 14. Acute Infection
Figure 15. Others
Figure 16. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size (2020-2031) & (US$ Million)
Figure 18. Global Intravenous Immunoglobulin(IVIg) Therapy Sales (2020-2031) & (K Units)
Figure 19. Global Intravenous Immunoglobulin(IVIg) Therapy Average Price (US$/Unit) & (2020-2031)
Figure 20. Intravenous Immunoglobulin(IVIg) Therapy Report Years Considered
Figure 21. Intravenous Immunoglobulin(IVIg) Therapy Sales Share by Manufacturers in 2024
Figure 22. Global Intravenous Immunoglobulin(IVIg) Therapy Revenue Share by Manufacturers in 2024
Figure 23. Global 5 and 10 Largest Intravenous Immunoglobulin(IVIg) Therapy Players: Market Share by Revenue in Intravenous Immunoglobulin(IVIg) Therapy in 2024
Figure 24. Intravenous Immunoglobulin(IVIg) Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Global Intravenous Immunoglobulin(IVIg) Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 26. North America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2020-2031)
Figure 27. North America Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2020-2031)
Figure 28. United States Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Canada Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Europe Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2020-2031)
Figure 31. Europe Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2020-2031)
Figure 32. Germany Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. France Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. U.K. Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Italy Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Russia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Region (2020-2031)
Figure 38. Asia Pacific Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Region (2020-2031)
Figure 39. China Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Japan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. South Korea Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. India Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Australia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. China Taiwan Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Southeast Asia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Latin America Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2020-2031)
Figure 47. Latin America Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2020-2031)
Figure 48. Mexico Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Brazil Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Argentina Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Sales Market Share by Country (2020-2031)
Figure 52. Middle East and Africa Intravenous Immunoglobulin(IVIg) Therapy Revenue Market Share by Country (2020-2031)
Figure 53. Turkey Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 54. Saudi Arabia Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 55. UAE Intravenous Immunoglobulin(IVIg) Therapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 56. Global Sales Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Type (2020-2031)
Figure 57. Global Revenue Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Type (2020-2031)
Figure 58. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Type (2020-2031)
Figure 59. Global Sales Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Application (2020-2031)
Figure 60. Global Revenue Market Share of Intravenous Immunoglobulin(IVIg) Therapy by Application (2020-2031)
Figure 61. Global Intravenous Immunoglobulin(IVIg) Therapy Price (US$/Unit) by Application (2020-2031)
Figure 62. Intravenous Immunoglobulin(IVIg) Therapy Value Chain
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
